- Home
- JTAI vs BDRX Comparison
JTAI vs BDRX Comparison
Compare JTAI & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JTAI
- BDRX
- Stock Information
- Founded
- JTAI 2018
- BDRX 2000
- Country
- JTAI United States
- BDRX United Kingdom
- Employees
- JTAI N/A
- BDRX 13
- Industry
- JTAI Blank Checks
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- JTAI Finance
- BDRX Health Care
- Exchange
- JTAI Nasdaq
- BDRX Nasdaq
- Market Cap
- JTAI 8.3M
- BDRX 3.9M
- IPO Year
- JTAI N/A
- BDRX N/A
- Fundamental
- Price
- JTAI $3.15
- BDRX $6.80
- Analyst Decision
- JTAI Strong Buy
- BDRX
- Analyst Count
- JTAI 1
- BDRX 0
- Target Price
- JTAI $11.00
- BDRX N/A
- AVG Volume (30 Days)
- JTAI 35.6K
- BDRX 53.1K
- Earning Date
- JTAI 11-13-2025
- BDRX 09-23-2025
- Dividend Yield
- JTAI N/A
- BDRX N/A
- EPS Growth
- JTAI N/A
- BDRX N/A
- EPS
- JTAI N/A
- BDRX N/A
- Revenue
- JTAI $12,790,684.00
- BDRX N/A
- Revenue This Year
- JTAI $13.37
- BDRX N/A
- Revenue Next Year
- JTAI $201.13
- BDRX N/A
- P/E Ratio
- JTAI N/A
- BDRX N/A
- Revenue Growth
- JTAI N/A
- BDRX N/A
- 52 Week Low
- JTAI $2.30
- BDRX $5.00
- 52 Week High
- JTAI $57.17
- BDRX $108.90
- Technical
- Relative Strength Index (RSI)
- JTAI 44.66
- BDRX 57.44
- Support Level
- JTAI $3.09
- BDRX $5.81
- Resistance Level
- JTAI $3.28
- BDRX $6.47
- Average True Range (ATR)
- JTAI 0.12
- BDRX 0.50
- MACD
- JTAI 0.01
- BDRX 0.20
- Stochastic Oscillator
- JTAI 21.95
- BDRX 97.30
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.